Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Publication/Presentation Date
1-27-2015
Volume
65
Issue
3
First Page
311
Last Page
312
ISSN
1558-3597
Published In/Presented At
Castaño, Adam et al. “Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?.” Journal of the American College of Cardiology vol. 65,3 (2015): 311-2. doi:10.1016/j.jacc.2014.09.084
Disciplines
Medicine and Health Sciences
PubMedID
25614433
Department(s)
Department of Medicine
Document Type
Article
COinS